Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TCDA | Common Stock | Purchase | $2.63M | +223K | +2.39% | $11.81* | 9.54M | Oct 4, 2022 | By Funds | F1, F2, F3 |
Id | Content |
---|---|
F1 | Consists of (i) 58,653 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (ii) 5,867 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (iii) 158,580 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"). |
F2 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.30 to $11.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F3 | VHCP Management II, LLC ("VHCPM II") is the general partner of Venrock Healthcare Capital Partners II, L.P. ("VHCP II") and the manager of VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"). VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein. |